氧化在体外模型中的心脏病综合征中起着双重作用
Giovana Marchini Armentano1, Joana Claudio Pieretti2, Carlos Alexandre Falconi3
1Laboratory of Cardiovascular Immunology, Center for Natural and Human Sciences (CCNH), Federal University of ABC (UFABC), Santo André, SP, Brazil, marcela.ramos@ufabc.edu.br.
概括
氧化 (NO) 在心综合征3 (CRS3) 中起着复杂的作用. 这项研究表明,NO信号和炎症分子是缺氧诱导的和心脏细胞反应的关键,影响CRS 3的发展.
科学领域:
- 心血管生理学心血管生理学
- 分子生物学分子生物学
- 蜂信号传输是如何进行的
背景情况:
- 氧化 (NO) 具有双重氧化剂/减氧剂作用,影响各种生物过程.
- 心脏病综合征3 (CRS3) 的发病包括炎症和反应性物种,但NO的确切作用尚不清楚.
- 了解NO的影响对于CRS3至关重要,这是一种影响心脏和脏的疾病.
研究的目的:
- 在心综合征3 (CRS3) 的体外模型中研究一氧化 (NO) 信号传导的作用.
- 在低氧条件下分析和心脏细胞中炎症分子的表达.
- 阐明CRS 3中NO和炎症反应之间的复杂相互作用.
主要方法:
- HEK293细胞经历过低氧 (HX) 或正常氧 (NX),有或没有L-NAME,然后对H9c2细胞进行调节.
- 使用MTT试验评估了细胞活力.
- 基因表达,NO含量 (度) 和炎症标志物 (IL-6,IL-10,TNF-α,IL-1β) 都被量化.
主要成果:
- 缺氧增加了碳酸酶9 (CA9) 表达,并降低了HEK293细胞活力,而L-NAME治疗恢复了这种活力.
- 细胞内NO含量在缺氧时显著下降,而TNF-α和Bax/Bcl2比率增加,L-NAME恢复了这些效应.
- 在H9c2细胞中,细胞外NO含量下降,从HX/L-NAME治疗的HEK293细胞中,IL-1β水平通过条件介质降低.
结论:
- 氧化 (NO) 在CRS 3相关的低氧诱导细胞反应中表现出复杂的作用.
- NO信号传递和炎症媒介在CRS 3的发病过程中密切相关.
- 这项研究通过突出NO的参与,提供了对CRS 3潜在治疗点的见解.
相关概念视频
01:28Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
01:23Antihypertensive Drugs: Vasodilators
525
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
525
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
645
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
645
01:25Antihypertensive Drugs: Direct Renin Inhibitors
630
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
630
01:16Antianginal Drugs: Nitrates and β-Blockers
592
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
592